Breakthrough T1D Young Adult Conference Schedule of Events
The Breakthrough T1D Young Adult Conference will be held March 30-31, 2019 in Dallas, Texas. Saturday, March 30 1:00 –…
SGLT Inhibition: It’s Not Just for Type 2 Anymore
Can a drug long-used for type 2 diabetes, also help those with T1D? The European body that approves medicines for…
We’re the Advancing Progress Type
Breakthrough T1D Fiscal Year 2018 Annual Report As you’ll see in the pages of our fiscal year 2018 annual report,…
Family is Everything: Teske Family Story
Read the inspiring story of the Teske family and their journey with type 1 diabetes. Learn how their dedication to…
In a Step Backward, UnitedHealthcare Changes Policy to Limit Insulin Pumps for Children
On February 1, 2019, UnitedHealthcare (UHC) announced a significant change to its insulin pump coverage policy, as it will no…
GK Activator Clinical Trial Results
A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body, and its expression…
Breakthrough T1D Leads Push to Develop a Vaccine for Viral Infections that Could Trigger T1D
Scientists worldwide are attempting to determine why some people predisposed to type 1 diabetes (T1D) eventually end up developing the…
March 2019 Young Adult Conference Speakers
The Breakthrough T1D Young Adult Conference is right around the corner. We’re thrilled to announce the following speakers and we…
An Important Step in the FDA Review of Sotagliflozin (Zynquista™) for T1D
You’ll hear it again and again: For some people with type 1 diabetes (T1D), SGLT inhibitor therapy* means taking less…
T1D Ambassador Eric Tozer to Run World Marathon Challenge
Starting on January 31, Breakthrough T1D Ambassador Eric Tozer will be participating in the 2019 World Marathon Challenges–7 marathons in…